X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
Details:
Under an exclusive licensing agreement, Aeolian has been granted a license that includes compositions and methods of use of pneumococcal vaccines in the U.S. and Japan, and pending in other geographies.
Lead Product(s): Multivalent Pneumococcal conjugate vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: iPCV22
Highest Development Status: PreclinicalProduct Type: Vaccine
Partner/Sponsor/Collaborator: Aeolian
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement January 30, 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
